DataSheet_1_Identification and Validation of Immune-Related Methylation Clusters for Predicting Immune Activity and Prognosis in Breast Cancer.pdf
The role of DNA methylation of breast cancer-infiltrating immune cells has not been fully explored. We conducted a cohort-based retrospective study analyzing the genome-wide immune-related DNA methylation of 1057 breast cancer patients from the TCGA cohort and GSE72308 cohort. Based on patients’ overall survival (OS), a prognostic risk score system using 18 immune-related methylation genes (IRMGs) was established and further validated in an independent cohort. Kaplan–Meier analysis showed a clear separation of OS between the low- and high-risk groups. Patients in the low-risk group had a higher immune score and stromal score compared with the high-risk group. Moreover, the characteristics based on 18-IRMGs signature were related to the tumor immune microenvironment and affected the abundance of tumor-infiltrating immune cells. Consistently, the 18-IRMGs signatures showed similar influences on immune modulation and survival in another external validation cohort (GSE72308). In conclusion, the proposed 18-IRMGs signature could be a potential marker for breast cancer prognostication.
History
References
- https://doi.org//10.1038/s41568-019-0142-8
- https://doi.org//10.1002/cac2.12078
- https://doi.org//10.1016/S0140-6736%2816%2931891-8
- https://doi.org//10.1186/s40880-018-0346-4
- https://doi.org//10.1001/jama.2018.19323
- https://doi.org//10.1016/j.cell.2019.03.005
- https://doi.org//10.1038/s41586-019-1876-x
- https://doi.org//10.1002/1878-0261.12747
- https://doi.org//10.1002/ijc.33009
- https://doi.org//10.1371/journal.pmed.1002194
- https://doi.org//10.1016/j.omtn.2020.06.001
- https://doi.org//10.1038/ng.3165
- https://doi.org//10.1038/nprot.2013.118
- https://doi.org//10.1038/s41421-020-0178-7
- https://doi.org//10.1038/s41467-017-00510-x
- https://doi.org//10.1038/nrg.2016.13
- https://doi.org//10.1186/s13059-014-0435-x
- https://doi.org//10.1038/s41591-018-0156-x
- https://doi.org//10.1016/j.molmed.2019.05.014
- https://doi.org//10.1186/s13148-019-0759-1
- https://doi.org//10.1186/s13148-019-0782-2
- https://doi.org//10.1016/S2213-2600%2818%2930284-4
- https://doi.org//10.1186/1471-2105-13-86
- https://doi.org//10.1038/s41467-018-07466-6
- https://doi.org//10.1186/s40880-019-0401-9
- https://doi.org//10.1038/nature26000
- https://doi.org//10.1172/JCI91095
- https://doi.org//10.1093/nar/gkv007
- https://doi.org//10.1002/%28SICI%291097-0258%2819970228%2916%3A4%3C385%3A%3AAID-SIM380%3E3.0.CO;2-3
- https://doi.org//10.18637/jss.v033.i01
- https://doi.org//10.1038/nmeth.3337
- https://doi.org//10.1186/s13059-017-1349-1
- https://doi.org//10.1038/ncomms3612
- https://doi.org//10.1002/sim.5958
- https://doi.org//10.1089/omi.2011.0118
- https://doi.org//10.1186/1471-2105-14-7
- https://doi.org//10.1002/emmm.201100801
- https://doi.org//10.1186/bcr2590
- https://doi.org//10.1016/j.molonc.2010.11.002
- https://doi.org//10.1186/s13148-020-00907-4
Usage metrics
Read the peer-reviewed publication
Categories
- Transplantation Immunology
- Tumour Immunology
- Immunology not elsewhere classified
- Immunology
- Veterinary Immunology
- Animal Immunology
- Genetic Immunology
- Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)
- Autoimmunity
- Cellular Immunology
- Humoural Immunology and Immunochemistry
- Immunogenetics (incl. Genetic Immunology)
- Innate Immunity